Mangalam Drugs And Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics has informed the stock exchanges that its trading window for dealing in securities will remain closed for designated persons (and their immediate relatives) starting October 1, 2025. The window will stay shut until 48 hours after the company declares its unaudited financial results for the period ended September 30, 2025 (Q2/H1 FY26). This is a routine compliance step mandated by SEBI's Insider Trading Regulations to prevent insider dealing ahead of the results announcement. Investors should expect the financial results to be declared in the coming weeks, after which the trading window will reopen.
This is a standard regulatory filing with no direct impact on shareholders. However, it signals that the company's Q2 FY26 financial results will be announced shortly, which could be a catalyst for stock movement depending on the numbers.